A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

Clinical trial NCT04633057 · COMPLETED

Trial details

NCT number: NCT04633057
Sponsor: TJ Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency

Start date: 2021-01-25
Primary completion: 2023-07-31
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.